ResearchMoz

Nanotechnology in Drug Delivery: Global Markets,

Cientifica
Published Date » 2012-01-16
No. Of Pages » 121

The report provides an in-depth presentation of recent developments (2000-2010) in nanoparticle-enabled DDS and future opportunities (2011-2021).  Persons with a financial or academic interest in the pharmaceutical industry who want to learn how advances in nanotechnology research and development will impact the economics of the pharmaceutical market will benefit most from this report.

This report will focus on a geographical breakdown of the developed NDD TAM for the period 2000-2010, with a forecast NDD TAM for the period 2011-2021. The values are presented in $USD as well as percentages.

In the decade since the international spotlight focused on nanotechnology, with some predicting a trillion dollar nanotech-enabled market by 2020, it has become increasingly clear from which areas of science and industry that market will materialise. Cientifica’s Global Funding of Nanotechnologies 2011 tracked the growth of government funding to a total of $67.5 billion from 2000 to 2011.

Nanotechnology in Drug Delivery: Global Markets, indicates nanotech-enabled drug delivery therapeutics is set to grow from a current value of $2.3 billion to $136 billion by the year 2021. This sector will therefore represent approximately 15% of the global nanotechnology market in 2021. Healthcare offers the greatest opportunity to add value to nanomaterials and China is the fastest-growing market sector.

Cientifica’s research indicates that global growth in the drug delivery market will be led by Asia with a compound annual growth rate (CAGR) of 32.5% between now and 2021. China will be the largest market for nanotechnology based drug delivery systems by 2021, worth more than $18 billion  and representing 43% of the Asian market.

France is forecast to surpass Japan as a drug delivery market within 10 years. Among European Union countries, the highest growth will be found in the former Eastern Bloc, and the lowest in the UK.
Table of Content

Executive Summary

Chapter 1

Report Scope
Thematic Scope
Scope of Data Analysis
Temporal Scope of Analysis
Geographical Scope
Report objective
Methodology
Calculation of CAGR
The Nanoscale

Chapter 2
Overview of nanotechnology
What are the Key Drivers for Adoption of Nanotechnology in Medicine and Biomedicine?
The Key Applications of Nanotechnology in Medicine and Biomedicine
How Nanotechnology Can Benefit Drug Delivery
How Nanotechnology Is Already Having An Impact On The Drug Delivery Sector

Chapter 3
Three Key Barriers to The Adoption of Nanotechnology in Medicine and Biomedicine
Five Current & Future Challenges in The Adoption of Nanotechnology in Medicine and Biomedicine

Chapter 4

Global Market Analysis: 2000-2010 (Without Segmentation)
Global Market Forecast: 2011-2021 (Without Segmentation)
Market Analysis Countries and Regions: 2000-2010 (With Segmentation)
Market Forecast Countries and Regions: 2011-2021 (With Segmentation)

Appendix
Publishing activity by organization (2000-2010)

Table of Exhibits

Table of Contents


Chapter One

Exhibit 1.1

Formula for the calculation of the Compound Annual Growth Rate (CAGR), (top).

Formula for the calculation of the Compound Annual Growth Rate (CAGR) in this report, for the 2011-2021 period, (bottom) [2].

Exhibit 1.2

Formula for the verification of the calculated values of the Compound Annual Growth Rate (CAGR), (top).

Formula for the verification of the calculated values of the Compound Annual Growth Rate (CAGR) in this report, for the 2011-2021 period, (bottom) [2].

Exhibit 1.3

Nanometres in a meter (top). Meters in a nanometre (bottom).

Chapter Two

Exhibit 2.1

The periodic table of elements, as we know it (at meter scale) is governed by classic Newtonian laws of physics. However, when perceived at nanoscale, those elements are governed by the laws of quantum physics.

Exhibit 2.2

Proportion of the population aged over 65 and over 80 [7].

Exhibit 2.3

Illustration of a diagram of each property of nanocarriers (size, shape, surface chemistry and mechanical properties) and their parameters subjected to optimization in order to improve their efficiency [10].

Chapter Three

Exhibit 3.1

Specified expected barriers in the development of particular types of nanoparticles (Courtesy of CienNanoroadmap Synthesis Report), [6].

Exhibit 3.2

Illustration of the measures adoption roadmap to combat/attenuate the key barriers to the adoption of nanotechnology in medicine and biomedicine (Source: Cientifica, Ltd.).

Exhibit 3.3

Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.4

Line chart representing Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.5

Bar chart representing Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.6

Table representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.7

Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.8

Bar chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Chapter Four:

Exhibit 4.8

Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, all countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.9

3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures in percentage).

Exhibit 4.10

Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.11

Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.12

3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.13

3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.14

3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, all world regions and countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.15

Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, all world regions and countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.16

3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures in percentage)

Exhibit 4.17

Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.18

Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.19

3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.20

3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.21

3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.22

Horizontal bar graph representing the Total Addressable Market, TAM In 2010, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.23

Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.24

3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.25

3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.46

Table representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions / countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.47

3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures in percentage).

Exhibit 4.48

Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.49

Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.50

3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.51

3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.52

3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.53

Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.54

Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.55

3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.56

3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.57

3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.58

Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.59

Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.60

3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.61

3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.62

3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.63

Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.64

Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.65

3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.66

3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Appendix

Exhibit A.1

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: North America; country: USA.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.2

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: Germany.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.3

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: France.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.4

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: UK.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.5

Table of publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. Country: Russian Federation.

Organizations are ordered alphabetically (increasing order).

Exhibit A.6

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: India.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.7

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: India.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.8

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: Japan.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.9

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: P R China.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.10

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: South Korea (Republic of Korea).

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.11

Table of publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. Asia; country: Taiwan.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Intelligent Network Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
An intelligent network has become one of the most critical technologies in the information industry because of its promising features like efficient network resource utilization, quick service deployment, vendor independence through standardization, and the separation of intelligence and switching functionality. An intelligent network is required for making networking smoother and for providing a reliable and flexible path for databases. It deals with the latest and new researches and the policies of telecommunication services. These networks are designed to satisfy many purposes such as...
Greece: kiwi fruit market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the kiwi market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the kiwi market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market...
Cancer Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.   Morbidity and...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

Loss recorded due to heavy investments carried out by Amazon
Jul 25, 2014  
Amazon.com Inc has been investing in newer businesses like consumer electronics and digital content, due to which it has been running into losses for some time now. The loss recorded in the second quarter was by far the highest. In 2014, the stock prices have dropped by 10% with reduced investor confidence in the long term growth investments. The shares of this US based online retailer...
LG Electronics To Invest Huge Capital in R&D Project in South Korea
Jul 25, 2014  
LG Electronics Inc will invest USD 1.26 billion in the construction of a new research and development unit in South Korea’s capital city Seoul. The facility is said to be part of LG’s Science Park project. The 170,000 square meters site will be built in Magok, Seoul and work is expected to begin from August. Once the construction is complete and ready by 2020, the park will house...
Russian Consumer Protection Agency Seeks ban on Some McDonalds Products
Jul 25, 2014  
A lawsuit has been filed in a Moscow court by the Russian consumer protection agency to seek ban on some products from McDonald's Corp's burgers menu, along with its ice creams and shakes menu.  A regional branch of the agency has recently filed a lawsuit asking the court to declare a ban on some products due to some inappropriateness in physical-chemical parameters in the...
High-sodium Diet Increases Risks of Cardiovascular Diseases in Type 2 Diabetics
Jul 24, 2014  
A new research has found relation between the amount of salt in diet of diabetics and their chances of suffering from cardiovascular diseases. The research has stated that diabetics who have a high-salt diet are on a higher risk of having a chronic heart disease as compared to the ones who eat less salt.  The study’s findings provide evidences that support the benefits of a...
Strides Arcolab Bags USFDA Approval for Transplant Drug
Jul 24, 2014  
Indian pharmaceutical company Strides Arcolab has received the approval of the USFDA to sell its transplant drug Tacrolimus in the US market. The capsule is an immune-suppressant that is used for preventing organ rejection that may occur in transplant surgeries of organs such as kidneys, heart or liver in some patients.  USFDA has allowed the sale of the tablets in 5 mg, 1 mg and 0.5...